News This UChicago Startup is Developing a Cure for Food Allergies Chances are we all know someone allergic to any one of either milk, eggs, peanuts, tree nuts, wheat, soy, fish, or shellfish, which are the eight most common type of...
News Record $1.6 Million Awarded in the 25th Anniversary Finals of Chicago Booth’s New Venture Challenge; First-Place Winner Andes STR Lands More Than $660,000 The Polsky Center for Entrepreneurship and Innovation at the University if Chicago has announced a record-breaking investment of $1.6 million in the winners of the 2021 Edward L. Kaplan, ’71, New...
Technology Lymphangiogenesis For Therapeutic Immunomodulation A vaccine platform that uses engineered lymphangiogenesis factors and antigens to stimulate lymphatic endothelial cells, creating strong, long-lasting immune memory or tolerance with fewer side effects than traditional vaccines The…
News Innovation Fund Invests $500,000 in Microbiome Research and Energy Companies The University of Chicago Innovation Fund announced plans to invest up to $500,000 into three companies—AVNovum, ClostraBio, and SwitchedSource—that are working in the health and energy fields, respectively. These latest...
News UChicago Food Allergy Startup Raises $3.5 Million Bunning Food Allergy Professor Cathy Nagler had been researching the physiological origins of food allergy and potential treatments for over 30 years without ever considering the possibility of translating that...
News Edward L. Kaplan, ’71, New Venture Challenge Investment Pool Swells to $1.73 Million After Additional Funding Rolls In; First-Place Winner Andes STR Gets $681,000 The record investment pool in the 25th annual Edward L. Kaplan, ’71, New Venture Challenge (NVC) jumped to $1.73 million this week after investors put additional money into the finalist...
Technology CD200-Antigen Fusion Proteins For Myeloid-Targeted Antigen-Specific Immune Tolerance CD200-antigen fusion proteins target myeloid cells to deliver inhibitory CD200R signals, enhancing antigen uptake and presentation while dampening inflammation to induce antigen-specific immune tolerance The Unmet Need: Antigen-specific therapies for…
Page Health & Life Sciences Novel treatments, medical devices, diagnostics, and research tools spanning a range of therapeutic areas.
News Scientist Builds Drug Development Company Out of Research Lab When Cathryn Nagler set out to develop drugs to treat childhood food allergies, she knew she was heading into unchartered territory. Although Nagler, the Bunning Food Allergy Professor, has been...
News Phase II Teams Selected for the New Venture Challenge The Polsky Center for Entrepreneurship and Innovation at the University of Chicago Booth School of Business has officially announced the 30 teams moving on to the next phase of the...
News UChicago Startup Gusto Brings Computational Modeling to Gut Health Maintaining harmony within the gut is extraordinarily important to the human body, as this microbiome interacts with the immune, hormone and nervous system. Not only can a disruption in the...
